Serum hyaluronic acid as a noninvasive marker of hepatic fibrosis in chronic hepatitis B

Saudi Journal of Gastroenterology

Volumn 14, Issue 4, 2008, Pages 174-177

  Geramizadeh, Bita ^a   Janfeshan, Katayoun ^a   Saberfiroozi, Mehdi ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatic fibrosis; Hepatitis B; Hyaluronic acid

Indexed keywords

EID: 53849121251     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.43274     Document Type: Article

References (13)

1. Montazeri G, Estakhri A, Mohamadnejad M, Nouri N, Montazeri F, Mohammadkani A, et al. Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterol 2005;5:32.
2. Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, et al. Prediction of significant fibrosis in HBeAg-Positive patients with Chronic Hepatitis B by a noninvasive model. Hepatology 2005;42:1437-45.
3. Adams LA, Bulsara M, Rossi E, Deboer B, Speers D, George J, et al. Hepascore: An accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clinical Chem 2005;51:1867-73.
4. Halfon P, Bourlière M, Pénaranda G, Deydier R Renou C, Botta-Fridlund C, et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. BMC Comp Hepatol 2005;4:6-13.
5. Chen YP, Feng XR, Dai L, Zhang L, Hou JL. Non-invasive diagnostic screening of hepatic fibrosis in patients with chronic hepatitis B. Chin Med J (Engl) 2004;117:1109-12.
6. Liang XH, Zheng H. Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis. Huang Yi Ke Da Xue Xue Bao 2002;28:67-8.
7. Zhang WS, Wang BE, Wng TL, Ou XJ, Chen Y, Li Q. Noninvasive assessment of liver fibrosis in chronic hepatitis B using a predictive model. Zhongua Gan Zang Bing Za Zhi 2006;14:169-73.
8. Yilmaz S, Bayan K, Tüzün Y, Dursun M, Kaplan A, Ozman S, et al. Replacement of histological findings: Serum hyaluronic acid for fibrosis, high sensitive C-reactive protein for necroinflammation in chronic viral hepatitis. Int J Clin Pract 2007;61:438-43.
9. Lebensztejn DM, Kaczmarski M, Sobaniec-Lotowska M, Bauer M, Voelker M, Schuppan D. Serum laminin-2 and hyaluronan predict severe liver fibrosis in children wih chronic hepatitis B. Hepatology 2004;39:868-9.
10. Fontana RJ, Goodman ZD, Dienstag Jl, Bonkovsky HL, Naishadham D, Sterling RK, et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology 2008;47:789-98.
11. Esmat G, Metwally M, Zalata KR, Gadalla S, Abdel-Hamid M, Abouzied A, et al: Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. J Hepatol 2007;46:620-7.
12. Tao J, Peng HQ, Cai WM, Dong FQ, Weng HL, Liu RH, et al. Influence factors of serum fibrosis markers in liver fibrosis. World J Gastroenterol 2003;9:2497-500.
13. Deng L, Zhuo Y, Peng X, Deng H, Yao J. Serum markers and Pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha. Zhongua Gan Zang Bing Za Zhi 2001;9:66-7.